← Open Payments lookup

JENNIFER BURROWS: Open Payments

NPI 1538439278 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$875 in 52 payments from 16 companies in 2025. Trend: 2023 $1,107 · 2024 $1,185 · 2025 $875

Food & beverage: $875
CompanyPaymentsAmount
Novo Nordisk Inc16$269
ABBVIE INC.10$148
AstraZeneca Pharmaceuticals LP5$82
PFIZER INC.3$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$53
Takeda Pharmaceuticals U.S.A., Inc.2$37
Axsome Therapeutics, Inc.2$34
Lilly USA, LLC2$33
Antares Pharma, Inc.2$32
Exact Sciences Corporation1$26

Products named: Rybelsus, UBRELVY, Ozempic, XIFAXAN, FARXIGA, VRAYLAR, PREVNAR 20, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.